{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T12:48:23Z","timestamp":1784033303137,"version":"3.55.0"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.seizure.2022.04.007","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T01:56:29Z","timestamp":1649901389000},"page":"101-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Trends in the prescription of anti-seizure medicines for pregnant women outpatients with epilepsy during 2016\u20132020 in Japan"],"prefix":"10.1016","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2251-008X","authenticated-orcid":false,"given":"Daisuke","family":"Kikuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3674-1674","authenticated-orcid":false,"given":"Taku","family":"Obara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Josaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misaki","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusuke","family":"Ouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5318-8882","authenticated-orcid":false,"given":"Kensuke","family":"Usui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7191-2857","authenticated-orcid":false,"given":"Kouji","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.seizure.2022.04.007_bib0001","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/jnnp-2013-306318","article-title":"Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland epilepsy and pregnancy registers","volume":"85","author":"Campbell","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.seizure.2022.04.007_bib0002","unstructured":"Japanese Society of Neurology. Epilepsy practice guidelines 2018, https:\/\/www.neurology-jp.org\/guidelinem\/tenkan_2018.html; 2018 [accessed 7 September 2021]."},{"key":"10.1016\/j.seizure.2022.04.007_bib0003","unstructured":"National Institute for Health and Care Excellence. Epilepsies: diagnosis and management clinical guideline [CG137], https:\/\/www.nice.org.uk\/guidance\/cg137\/chapter\/1-Guidance#women-and-girls-with-epilepsy; 2021 [accessed 7 September 2021]."},{"key":"10.1016\/j.seizure.2022.04.007_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108549","article-title":"Twenty-year trends in the use of anti-seizure medication among pregnant women in the Netherlands","volume":"127","author":"Houben","year":"2022","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2022.04.007_bib0005","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/pds.4749","article-title":"Examination of the prescription of antiepileptic drugs to prenatal and postpartum women in Japan from a health administrative database","volume":"28","author":"Ishikawa","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"10.1016\/j.seizure.2022.04.007_bib0006","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/pds.5035","article-title":"Prevalence trends and individual patterns of antiepileptic drug use in pregnancy 2006\u20132016: a study in the five Nordic countries, United States, and Australia","volume":"29","author":"Cohen","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.seizure.2022.04.007_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2020.102512","article-title":"Drug prescription for attention deficit hyperactivity disorder drugs in pediatric outpatients: a retrospective survey of Japanese administrative data (2012-2018)","volume":"57","author":"Kikuchi","year":"2021","journal-title":"Asian J Psychiatr"},{"key":"10.1016\/j.seizure.2022.04.007_bib0008","unstructured":"World Health Organization. International statistical classification of diseases and related health problems, https:\/\/www.who.int\/standards\/classifications\/classification-of-diseases; 2021 [accessed 7 September 2021]."},{"issue":"9","key":"10.1016\/j.seizure.2022.04.007_bib0009","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1468-1331.2009.02748.x","article-title":"European federation of neurological societies. EFNS guideline on the drug treatment of migraine\u2013revised report of an EFNS task force","volume":"16","author":"Evers","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.seizure.2022.04.007_bib0010","unstructured":"Japanese Headache Society. Guideline for migraine treatment by valproic acid, https:\/\/www.neurology-jp.org\/guidelinem\/ch\/documents\/appendix-II.pdf; 2013 [accessed 1 April 2022]."},{"key":"10.1016\/j.seizure.2022.04.007_bib0011","unstructured":"American Epilepsy Society. Epilepsies: position statement on the use of valproate by women of childbearing potential, https:\/\/cms.aesnet.org\/about\/position-statements\/position-statement-on-the-use-of-valproate-by-women-of-childbearing-potential; 2021 [accessed 7 September 2021]."},{"key":"10.1016\/j.seizure.2022.04.007_bib0012","unstructured":"Pharmaceuticals and Medical Devices Agency. Compliance with dosage and administration and ensuring early detection for Lamictal tablets (lamotrigine)-induced serious skin disorders, https:\/\/www.pmda.go.jp\/files\/000153788.pdf; 2012 [accessed 1 April 2022]."}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131122000899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131122000899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T02:00:20Z","timestamp":1761012020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131122000899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":12,"alternative-id":["S1059131122000899"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2022.04.007","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in the prescription of anti-seizure medicines for pregnant women outpatients with epilepsy during 2016\u20132020 in Japan","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2022.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}